Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA). [electronic resource]
Producer: 20040621Description: 1093-8 p. digitalISSN:- 0196-9781
- Administration, Intranasal
- Antiretroviral Therapy, Highly Active
- Antiviral Agents -- therapeutic use
- CD4 Lymphocyte Count
- CD8-Positive T-Lymphocytes -- chemistry
- Coculture Techniques
- DNA, Viral -- analysis
- HIV Core Protein p24 -- analysis
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Lipopolysaccharide Receptors -- analysis
- Macrophages -- chemistry
- Monocytes -- chemistry
- Neutrophils -- chemistry
- Peptide T -- pharmacology
- Polymerase Chain Reaction
- RNA, Viral -- blood
- Viral Load
- Virus Integration -- drug effects
- Virus Replication -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.